title: Influence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic Center.
abstract: Background We aimed to carry out comparison of different bleeding avoidance strategies in doing primary percutaneous coronary intervention (PPCI) using either radial or femoral as access of choice and either bivalirudin or unfractionated heparin as anticoagulant of choice. In this analysis, we analyzed the influence of major bleeding definition on bleeding outcomes as well. Methods We did a retrospective analysis of 139 patients with ST-segment elevation myocardial infarction (STEMI) who had PPCI in our academic center from January 2010 till October 2013. The primary outcome at 30 days was a composite of death from any cause or stent thrombosis or non-coronary artery bypass grafting (CABG) related major bleeding (CathPCI Registry definition) and secondary outcomes were individual components of primary outcome and the hospital length of stay. Results There was no significant difference among different access/anticoagulant combinations with regards to primary outcome (22% in radial/bivalirudin vs. 5% in radial/heparin vs. 17% in femoral/bivalirudin vs. 28% in femoral/heparin group; p = 0.2) as well as its individual components except the hospital length of stay (2.56 vs. 3 vs. 3.97 vs. 4.4 days each; p < 0.0001). The overall rate of major bleeding was 11.5%. When we use HORIZON-AMI bleeding definition, it went up to 25 % due to one particular component (p < 0.004). Conclusions This single center observational study doing PPCI did not show any superiority of one bleeding avoidance strategy over others with regard to primary outcome and its individual components except the hospital length of stay. It also shows the importance of bleeding definition on bleeding outcomes.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: M K
authors.initials: MK
authors.lastname: Bheemarasetti
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: S
authors.initials: S
authors.lastname: Shawar
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: S
authors.initials: S
authors.lastname: Chithri
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: W I
authors.initials: WI
authors.lastname: Khalife
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: U M
authors.initials: UM
authors.lastname: Rangasetty
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: K
authors.initials: K
authors.lastname: Fujise
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
authors.forename: S A
authors.initials: SA
authors.lastname: Gilani
keywords: bivalirudin; bleeding definition; radial access